Please login to the form below

Social listening report: Is COVID-19 impacting clinical trial recruitment?

The short answer, perhaps obviously, is yes.

Here at COUCH Health, we’ve been doing some social listening to work out how the COVID-19 pandemic is affecting clinical trials and product development for other conditions. Of course, at the moment, most online discussions about clinical research surround the latest developments in COVID-19 trials. Everyone is working hard to investigate vaccines, better diagnostic tests and treatments. The most common emotion revealed in our analysis was fear. And this isn’t surprising, since the uncertainty of the pandemic is affecting us all in so many ways.

Outside of COVID-19 research, clinical trials are being impacted regardless of indication. The FDA has encouraged clinical trials to pause unless they serve an immediate benefit. Some trials are taking the opportunity to decentralise their study assessments, using saliva collection kits that can be used at home and posted for testing instead. That way, the trial can keep move forwards and enrolment can still be encouraged. But it’s not just the routine appointments for participants that are being affected:

  • Screening is unable to go ahead as patients can’t visit study clinics and many clinicians are working from home, where they can.
  • Research groups that run lab work are putting operations on hold to devote resources to COVID-19.
  • COVID-19 testing is not part of trial protocols and patients may need to be removed from study populations for safety reasons.

Our insights have revealed that lots of people are worried about attending appointments because of the risks of COVID-19. These feelings would undoubtedly translate to the clinical trials, too.

“Must admit I am not looking forward to going to the hospital as I believe they could be riddled with COVID-19.”
– MS patient

And a survey in the US found that almost 40% of study sites believe that patients will be less willing to consentto take part in a new clinical trial.

Like never before, COVID-19 has forced the pharmaceutical industry to step up, expedite processes and re-evaluate priorities. While this does mean that resources are being diverted to focus on COVID-19, it’s equally important that progress doesn’t stop for other conditions. Clinical trial teams will need to adapt, decentralise, and go the extra mile to reassure patients that taking part is safe.

For more insights on how the clinical trial space is changing in light of COVID-19, take a look at more of our findings by downloading the document. And if you’re wondering how your study could benefit from improved patient engagement or virtual activities during these challenging times, we’re here to help.

This blog was originally posted here:


  COVID-19 Social Listening Report
PDF File: 1.8 MB

18th April 2020


  COVID-19 Social Listening Report
PDF File: 1.8 MB



Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Suite 2.10, Jactin House
24 Hood Street
M4 6WX
United Kingdom

Latest content on this profile

Clinical trial recruitment on podcasts: is it a good idea?
The pharmaceutical industry is already using social media and search engine advertising for clinical trials, so why not consider podcast platforms too?
COUCH Health
How community outreach can help improve diversity in clinical research
To execute a considered community engagement strategy, an involved and collaborative process is needed.
COUCH Health
Can eLearning improve patient recruitment and retention?
Some patients will still want to read pages of informed consent forms before joining a clinical trial, or want timely updates on paper rather than a notification on their phone. Whereas some would prefer to see a virtual reminder, watch videos, and take online questionnaires. The point is: there needs to be options. And that’s where eLearning comes in.
COUCH Health
Whats the difference between patient engagement and patient experience?
We all talk a lot about patient engagement and patient experience. And sometimes, these terms are used interchangeably across the industry. But while they’re both important, they’re not the same. So, let’s quickly clear up once and for all what the difference between patient engagement and patient experience is, so we can make sure that we’re doing the best possible job in both areas…
COUCH Health
Building trust in clinical trials whilst it is in the public eye
We’re all well aware that healthcare organisations are generally perceived to be untrustworthy. According to Edelman’s 2018 Trust Barometer, we even saw a clear global decline of public trust in pharma, biotech, hospitals, insurance and consumer health companies.
COUCH Health
Diversity in clinical trials needs to extend beyond COVID-19 vaccine trails
First up, the hard truth is that clinical trial populations are not diverse. People of certain ethnicities, females and the elderly are typically underrepresented in clinical research. And you might ask, “why?”
COUCH Health